Related Experiment Video
Updated: Jun 15, 2026

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement
Arin B Aurora1, Aryn B Aurora, Dauren Biyashev
1Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Abstract:
Extracellular factors control the angiogenic switch in endothelial cells (ECs) via competing survival and apoptotic pathways. Previously, we showed that proangiogenic and antiangiogenic factors target the same signaling molecules, which thereby become pivots of angiogenic balance. Here we show that in remodeling endothelium (ECs and EC precursors) natural angiogenic inhibitors enhance nuclear factor-kappaB (NF-kappaB) DNA binding, which is critical for antiangiogenesis, and that blocking the NF-kappaB pathway abolishes multiple antiangiogenic events in vitro and in vivo. NF-kappaB induction by antiangiogenic molecules has a dual effect on transcription. NF-kappaB acts as an activator of proapoptotic FasL and as a repressor of prosurvival cFLIP. On the FasL promoter, NF-kappaB increases the recruitment of HAT p300 and acetylated histones H3 and H4. Conversely, on cFLIP promoter, NF-kappaB increases histone deacetylase 1 (HDAC1), decreases p300 and histone acetylation, and reduces the recruitment of NFAT, a transcription factor critical for cFLIP expression. Finally, we found a biphasic effect, when HDAC inhibitors (HDACi) were used to test the dependence of pigment epithelial-derived factor activity on histone acetylation. The cooperative effect seen at low doses switches to antagonistic as the concentrations increase. Our study defines an interactive transcriptional network underlying angiogenic balance and points to HDACi as tools to manipulate the angiogenic switch.
Insights
Natural angiogenic inhibitors enhance nuclear factor-kappaB (NF-kappaB) DNA binding, crucial for antiangiogenesis. Blocking this pathway disrupts antiangiogenic events, offering new therapeutic strategies for controlling blood vessel formation.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Extracellular factors regulate endothelial cell (EC) survival and apoptosis, controlling the angiogenic switch.
- Proangiogenic and antiangiogenic factors converge on shared signaling molecules, influencing angiogenic balance.
- The nuclear factor-kappaB (NF-kappaB) pathway plays a critical role in regulating angiogenesis.
Purpose of the Study:
- To investigate the role of NF-kappaB in antiangiogenesis mediated by natural inhibitors.
- To elucidate the transcriptional mechanisms by which NF-kappaB regulates proapoptotic and prosurvival factors.
- To explore the potential of histone deacetylase inhibitors (HDACi) in modulating the angiogenic switch.
Main Methods:
- Assessed NF-kappaB DNA binding in remodeling endothelium.
- Investigated the effect of blocking the NF-kappaB pathway on antiangiogenic events in vitro and in vivo.
- Analyzed NF-kappaB's transcriptional regulation of FasL and cFLIP promoters.
- Examined the impact of HDAC inhibitors on pigment epithelial-derived factor activity and histone acetylation.
Main Results:
- Natural angiogenic inhibitors enhance NF-kappaB DNA binding, essential for antiangiogenesis.
- Blocking NF-kappaB abrogates multiple in vitro and in vivo antiangiogenic effects.
- NF-kappaB activates proapoptotic FasL transcription by increasing HAT p300 and histone acetylation.
- NF-kappaB represses prosurvival cFLIP transcription by increasing HDAC1 and decreasing histone acetylation.
- HDAC inhibitors exhibit a dose-dependent biphasic effect on pigment epithelial-derived factor activity.
Conclusions:
- A complex transcriptional network governs angiogenic balance, involving NF-kappaB-mediated regulation of key apoptotic and survival genes.
- Targeting the NF-kappaB pathway and histone acetylation presents a viable strategy for manipulating the angiogenic switch.
- HDAC inhibitors show promise as therapeutic tools for controlling angiogenesis.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Mechanism of Angiogenesis
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Regulation of Nuclear Protein Sorting

